FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/ILMN
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Illumina, Inc. (ILMN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Illumina (ILMN) trades at $235.99, down 18.28% in the last 24 hours, following a period of strong performance that saw it reach a 52-week high near $279. The stock exhibits a bullish technical trend with consistent earnings beats in recent quarters. Fundamentally, the company reported $850M net income for 2025, a significant turnaround from prior losses, with robust gross margins of 66.38%. Recent news highlights S&P 500 inclusion and AI-driven growth initiatives in genomics.
The outlook for ILMN is positive, supported by earnings momentum, strategic AI investments, and analyst optimism, with a consensus price target of $252.73. Key risks include valuation multiples above sector averages, competitive pressures in genomics, and potential margin volatility from cost fluctuations. The stock's recent pullback may present a buying opportunity for investors bullish on its long-term growth in precision medicine.
Read full analysis

Key Stats

  • Market Cap
    $43.80B
  • Volume
    2,017,152
  • Sector
    Health
  • 52W High
    $293.69
  • 52W Low
    $99.01
  • Typical Hold Time
    84 Days
  • Enterprise Value
    $45.16B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$235.99
52W Low: $99.01
30 Oct 2025
52W High: $293.69
05 Oct 2026

Track Illumina, Inc. (ILMN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Illumina, Inc. has traded between a low of $99.01 and a high of $293.69, highlighting its annual price range. Buy and sell Illumina, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Most Recent News

Content is generated by Aura AI

3E Network faces Nasdaq delisting over low share price, plans hearing to appeal and regain compliance.

3E Network Technology Group Limited received a notice from Nasdaq that its Class A shares will be delisted due to the share price falling below $1.00 for 30 consecutive business days. The company is not eligible for a compliance period because of a r...

Market News
4 hours ago
Na
Bearish
news icon
3E Network faces Nasdaq delisting over low share price, plans hearing to appeal and regain compliance.

Lawsuit investigation launched over J.B. Hunt's alleged misleading earnings info causing stock drop

The Rosen Law Firm is investigating potential securities claims against J.B. Hunt Transport Services following a sharp 10% stock drop after the company warned of lower third-quarter earnings due to increased costs. Investors who purchased J.B. Hunt s...

Market News
4 hours ago
GlobeNewsWire
Bearish
news icon
Lawsuit investigation launched over J.B. Hunt's alleged misleading earnings info causing stock drop

Philips launches HyperVue Integrated System in the U.S. for advanced coronary imaging and physiology in cath labs

Philips has introduced the HyperVue Integrated System in the U.S., a fixed, single-room setup combining DeepOCT+NIRS imaging with X1-FFR physiology assessment for coronary interventions. This system is designed to streamline cath lab workflows by kee...

Others
4 hours ago
Not Specified
Bullish
news icon
Philips launches HyperVue Integrated System in the U.S. for advanced coronary imaging and physiology in cath labs
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $43.80B
  • Volume
    2,017,152
  • Sector
    Health
  • 52W High
    $293.69
  • 52W Low
    $99.01
  • Typical Hold Time
    84 Days
  • Enterprise Value
    $45.16B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$235.99
52W Low: $99.01
30 Oct 2025
52W High: $293.69
05 Oct 2026

Track Illumina, Inc. (ILMN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Illumina, Inc. has traded between a low of $99.01 and a high of $293.69, highlighting its annual price range. Buy and sell Illumina, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!